| 英文名称 |
中文名称 |
CAS号 |
操作 |
| Vecabrutinib Impurity 22 |
脱氮黄素 |
26908-38-3 |
详细
|
| Vecabrutinib Impurity 23 |
四烯甲萘醌杂质2 |
70662-30-5 |
详细
|
| Vecabrutinib Impurity 10 |
6-(difluoromethoxy)-1,2,3,4-tetrahydroquinoline |
954264-62-1 |
详细
|
| Vecabrutinib Impurity 11 |
6,7-二甲氧基-3-甲基喹唑啉-2,4(1H,3H)-二酮 |
20197-88-0 |
详细
|
| Vecabrutinib Impurity 12 |
4-苯基-3,4-二氢喹唑啉-2(1H)-酮 |
107289-02-1 |
详细
|
| Vecabrutinib Impurity 13 |
|
119198-23-1 |
详细
|
| Vecabrutinib Impurity 14 |
2,4-二羟基-6,7-二乙氧基喹唑啉 |
20197-80-2 |
详细
|
| Vecabrutinib Impurity 15 |
|
199186-62-4 |
详细
|
| Vecabrutinib Impurity 16 |
|
199188-80-2 |
详细
|
| Vecabrutinib Impurity 17 |
3,4-二氢-3-甲基-2(1H)-喹唑啉酮 |
24365-65-9 |
详细
|
| Vecabrutinib Impurity 18 |
|
17730-75-5 |
详细
|
| Vecabrutinib Impurity 21 |
羟甲唑啉杂质3 盐酸盐 |
205035-03-6 |
详细
|
| Vecabrutinib Impurity 9 |
3-(2-氯乙基)-6,7-二甲氧基-1H-喹唑啉-2,4-二酮 |
110231-26-0 |
详细
|
| Vibegron |
维生素K2杂质05 |
110327-29-2 |
详细
|
| Mepyramine Impurity 20 |
|
1631061-69-2 |
详细
|
| Mepyramine Impurity 18 |
|
1360459-08-0 |
详细
|
| Mepyramine Impurity 9 |
|
1360458-91-8 |
详细
|
| Mepyramine Impurity 10 |
|
1360458-97-4 |
详细
|
| Mepyramine Impurity 11 |
|
1631061-63-6 |
详细
|
| Mepyramine Impurity 12 |
|
1360459-07-9 |
详细
|
| Mepyramine Impurity 13 |
|
1360459-16-0 |
详细
|
| Mepyramine Impurity 14 |
|
1360459-17-1 |
详细
|
| Mepyramine Impurity 15 |
|
1360458-93-0 |
详细
|
| Mepyramine Impurity 16 |
|
1360459-06-8 |
详细
|
| Mepyramine Impurity 17 |
|
1631061-67-0 |
详细
|
| Mepyramine Impurity 21 |
|
1030595-44-8 |
详细
|
| Mepyramine Impurity 22 |
|
1360459-01-3 |
详细
|
| Mepyramine Impurity 19 |
|
1360459-13-7 |
详细
|
| Rasagiline Impurity 40 |
|
1631061-76-1 |
详细
|
| Rasagiline Impurity 41 |
4'-C-叠氮基-3'-脱氧-3'-氟胞苷 |
1145869-46-0 |
详细
|
| Rasagiline Impurity 42 |
|
1030595-43-7 |
详细
|
| Rasagiline Impurity 43 |
|
1360459-02-4 |
详细
|
| Phenylbutazone Impurity 5 Sulfate (Phenylbutazone EP Impurity E Sulfate) |
AHLBNYSZXLDEJQ-HDVRVJOHSA-N |
1356930-46-5 |
详细
|
| Phenylbutazone Impurity 14 |
N-DEFORMYL-N-PIVALOYL ORLISTAT |
1356017-35-0 |
详细
|
| Phenylbutazone Impurity 15 |
N-DEFORMYL-N-BENZYLOXYCARBONYL ORLISTAT |
108051-94-1 |
详细
|
| Phenylbutazone Impurity 16 |
(R,S,S,S)-Orlistat Tetradecyl Ester |
1356019-45-8 |
详细
|
| Phenylbutazone Impurity 17 |
XMSSICJSZNPVFX-BMSJAHLVSA-N |
1329647-21-3 |
详细
|
| Phenylbutazone Impurity 18 |
N,N-DideMethylorphenadrine Hydrochloride |
17752-32-8 |
详细
|
| Phenylbutazone Impurity 19 |
(R)-Orphenadrine Citrate |
1202395-79-6 |
详细
|
| Rasagiline Impurity 39 |
|
1631061-75-0 |
详细
|
| Mepyramine Impurity 26 |
|
1360459-33-1 |
详细
|
| Mepyramine Impurity 23 |
|
1360459-09-1 |
详细
|
| Mepyramine Impurity 24 |
|
1360459-05-7 |
详细
|
| Mepyramine Impurity 25 |
|
1360459-10-4 |
详细
|
| Rasagiline Impurity 35 |
|
1360459-50-2 |
详细
|
| Rasagiline Impurity 36 |
|
1360459-39-7 |
详细
|
| Rasagiline Impurity 37 |
|
1360459-46-6 |
详细
|
| Rasagiline Impurity 38 |
|
1631061-74-9 |
详细
|
| Polmacoxib Impurity 4 |
PT2977 |
1672668-24-4 |
详细
|
| Polmacoxib Impurity 5 |
|
1672668-51-7 |
详细
|
| Polmacoxib Impurity 6 |
|
2007088-15-3 |
详细
|
| Polmacoxib Impurity 11 |
|
1672668-35-7 |
详细
|
| Polmacoxib Impurity 12 |
|
1672668-50-6 |
详细
|
| Polmacoxib Impurity 13 |
|
2007088-16-4 |
详细
|
| Polmacoxib Impurity 14 |
|
2055231-72-4 |
详细
|
| Phenylbutazone Impurity 21 |
奥司他韦酸-D3 |
1242184-43-5 |
详细
|
| Phenylbutazone Impurity 22 |
5-(乙酰氨基)-4-氨基-3-(1-乙基丙氧基)-1-环己烯-1-羧酸 |
1391047-93-0 |
详细
|
| Phenylbutazone Impurity 23 |
(3S,4S,5R)-4-(乙酰氨基)-5-氨基-3-(1-乙基丙氧基)-1-环己烯-1-羧酸乙酯磷酸盐 |
1035895-89-6 |
详细
|
| Phenylbutazone Impurity 24 |
OseltaMivir Acid PotassiuM Salt |
1363339-68-7 |
详细
|
| Phenylbutazone Impurity 25 |
奥司他韦杂质 |
1415963-60-8 |
详细
|
| Phenylbutazone Impurity 26 |
奥司他韦13CD3 |
1093851-61-6 |
详细
|
| Phenylbutazone Impurity 28 |
2-[4-[(E)-4-chloro-1,2-diphenylbut-1-enyl]phenoxy]ethanol |
238089-02-6 |
详细
|
| Phenylbutazone Impurity 31 |
氟氯西林杂质7 |
42947-70-6 |
详细
|
| Phenylbutazone Impurity 32 |
氯唑苄星青霉素 |
23736-58-5 |
详细
|
| Osimertinib-13C,d3 |
奥斯替尼-13C,d3 |
2254100-49-5 |
详细
|
| Polmacoxib Impurity 15 |
|
2826252-90-6 |
详细
|
| Polmacoxib Impurity 16 |
|
2826252-91-7 |
详细
|
| Polmacoxib Impurity 17 |
|
2826252-92-8 |
详细
|
| Phenylbutazone Impurity 35 |
3,4-二氟肉桂酸 |
112897-97-9 |
详细
|
| Polmacoxib |
376608-67-2 |
376608-67-2 |
详细
|
| Polmacoxib Impurity 1 |
376608-68-3 |
376608-68-3 |
详细
|
| Polmacoxib Impurity 3 |
替格瑞洛杂质8 |
378236-67-0 |
详细
|
| Polmacoxib Impurity 18 |
|
2826252-93-9 |
详细
|
| Polmacoxib Impurity 19 |
|
2826252-94-0 |
详细
|
| Polmacoxib Impurity 20 |
|
1672668-30-2 |
详细
|
| Polmacoxib Impurity 21 |
|
2365402-28-2 |
详细
|
| Polmacoxib Impurity 22 |
|
1672668-39-1 |
详细
|
| Polmacoxib Impurity 23 |
|
1672668-44-8 |
详细
|
| Polmacoxib Impurity 24 |
|
2738682-45-4 |
详细
|
| Polmacoxib Impurity 25 |
|
2370102-07-9 |
详细
|
| Polmacoxib Impurity 26 |
|
2370015-98-6 |
详细
|
| Vecabrutinib |
3-(哌啶-4-基)-3,4-二氢喹唑啉-2(1H)-酮 |
79098-75-2 |
详细
|
| Vecabrutinib Impurity 1 |
|
79098-88-7 |
详细
|
| Vecabrutinib Impurity 2 |
6-羟基-3,4-二氢喹唑啉-2(1H)-酮 |
948552-89-4 |
详细
|
| Vecabrutinib Impurity 3 |
5-(三氟甲氧基)吲哚酮 |
403853-48-5 |
详细
|
| Vecabrutinib Impurity 4 |
8-(difluoromethoxy)-1,2,3,4-tetrahydroquinoline |
953735-66-5 |
详细
|
| Vecabrutinib Impurity 5 |
N-(4-(三氟甲氧基)苯基)哌啶-4-胺 |
681482-48-4 |
详细
|
| Vecabrutinib Impurity 6 |
3-(2-羟基乙基)-6,7-二甲氧基-1H-喹唑啉-2,4-二酮 |
110231-25-9 |
详细
|
| Vecabrutinib Impurity 7 |
3-乙基-6,7-二甲氧基-1H-喹唑啉-2,4-二酮 |
335417-99-7 |
详细
|
| Vecabrutinib Impurity 8 |
3-(3-氯苯基)-6,7-二甲氧基-1H-喹唑啉-2,4-二酮 |
364748-38-9 |
详细
|
| Vibegron Impurity 1 |
四烯甲萘醌杂质3 |
55700-10-2 |
详细
|
| Vibegron Impurity 8 |
|
210095-51-5 |
详细
|
| Vibegron Impurity 7 |
|
2370016-14-9 |
详细
|
| Vibegron Impurity 4 |
阿哌沙班杂质93 |
40345-06-0 |
详细
|
| Vibegron Impurity 3 |
1-(N-tryptophan)-1-deoxyfructose |
25020-15-9 |
详细
|
| Vibegron Impurity 2 |
MENAQUINONE 4 2,3-EPOXIDE |
72908-86-2 |
详细
|
| Vibegron Impurity 6 |
|
2370016-04-7 |
详细
|
| Vibegron Impurity 5 |
|
2883232-91-3 |
详细
|
| Vibegron Impurity 11 |
3-丁氧基-4-硝基苯甲酸 |
72101-53-2 |
详细
|
| Vibegron Impurity 9 |
125602-69-9 |
125602-69-9 |
详细
|